RT Journal Article
SR Electronic
T1 A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 127
DO 10.1186/s40425-019-0615-z
VO 7
IS 1
A1 Ornstein, Moshe C.
A1 Wood, Laura S.
A1 Hobbs, Brian P.
A1 Allman, Kimberly D.
A1 Martin, Allison
A1 Bevan, Michael
A1 Gilligan, Timothy D.
A1 Garcia, Jorge A.
A1 Rini, Brian I.
YR 2019
UL http://jitc.bmj.com/content/7/1/127.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.